InvestorsHub Logo
Followers 74
Posts 9173
Boards Moderated 0
Alias Born 04/25/2002

Re: None

Thursday, 10/19/2017 4:27:33 PM

Thursday, October 19, 2017 4:27:33 PM

Post# of 272
Thinly traded nano cap Aevi Genomic Medicine (GNMX +12.5%) jumps on a 9x surge in volume in apparent response to Form 4 filings after the close yesterday disclosing stock purchases by insiders.

CEO Michael Cola: 119,047 shares at $1.26.

CSO Garry Neil, M.D.: 75,000 shares at $1.26.

Director Eugene Bauer: 19,841 shares at $1.26.

Director Alastair Clemow: 19,841 shares at $1.26.

Director Barbara Duncan: 59,524 shares at $1.26.

Director Wilbur Gantz: 39,683 shares at $1.26.

Director Joseph Grano: 39,683 shares at $1.26.

Director Sol Barer: 421,032 shares at $1.26.